Compare Alcon AG (ALC) vs NetFlix Inc (NFLX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs NetFlix Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while NetFlix Inc trades at $75.61 (market cap $320.78B). The key difference: NetFlix Inc is far larger — about 9.8× Alcon AG's market cap, and Alcon AG pays a 0.54% dividend while NetFlix Inc pays none. Which is the better fit depends on your goals.
| ALC | NFLX | |
|---|---|---|
Market Cap | $32.69B | $320.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $128.83 |
52-Week Low | $62.02 | $70.91 |
Enterprise Value | $36.28B | $322.85B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Netflix (NFLX) trades at $75.59, down 0.57% on the day, and is in a bearish technical trend. The stock faces headwinds despite strong fundamentals, including a 28.5% net income margin and robust revenue growth, with Q1 2026 EPS beating expectations. Recent news highlights a losing streak and debates over its growth versus value proposition. Analyst consensus remains bullish with a $114.75 price target, suggesting significant upside from current levels.
The outlook for NFLX hinges on scaling its advertising business and maintaining subscriber growth amid competition. Key risks include market sentiment shifts and execution on new revenue streams. With high profitability and analyst confidence, the stock presents a long-term opportunity if it can capitalize on its ad-tier expansion and content strategy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About NetFlix Inc
Netflix Inc. is an Internet subscription service for watching television shows and movies. Subscribers can instantly watch unlimited television shows and movies streamed over the Internet to their televisions, computers, and mobile devices and in the United States, subscribers can receive standard definition DVDs and Blu-ray Discs delivered to their homes.
Read more on NFLX →
